Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2120 of 6351
-
Can treating the mind heal the shoulder? a surgery study investigates
Knowledge-focused CompletedThis prospective cohort study evaluated how depressive symptom severity changes during the first 2 years after arthroscopic rotator cuff repair, and whether changes in depressive symptoms are associated with improvements in shoulder pain and function. Adults who underwent arthros…
Sponsor: Chuncheon Sacred Heart Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Mild electric current may deliver bowel medication through skin, no needles needed
Disease control CompletedBowel care (BC) is a time-consuming and cumbersome activity of daily living for most individuals with SCI. Previous studies have reported that the average time to complete a BC routine is 45 minutes; 10-20% of SCI individuals report BC routines lasting for more than 1 hour. In pa…
Early phase 1 • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Bladder cancer battle: which chemo regimen wins before or after surgery?
Disease control CompletedRadical cystectomy remains the gold standard treatment for invasive non metastatic transitional cell cancer (TCC) of the bladder. In contemporary series, specific survival rates are about 60 to 65% at 5 years, decreasing for locally advanced disease to 45-50% in patients with non…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New laser device could catch spreading melanoma cells in real time
Diagnosis Recruiting nowThe objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitu…
Sponsor: University of Arkansas • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New scope test could sharpen lung cancer staging, spare patients unnecessary radiation
Diagnosis Recruiting nowIt is reported that more than 90,000 patients died of lung cancer and more than 20% of them were older than 80 years in North America. Therefore a less invasive but effective treatment is required for patients with lung cancer of advanced age, diminished pulmonary functions, and …
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Can a targeted nerve block cut opioid use and boost blood flow after leg bypass?
Symptom relief CompletedThe aim of this study is to assess, in patients scheduled for femoropopliteal bypass, the benefit of a double peripheral nerve block (femoral + sciatic) with levobupivacaine and clonidine in a single dose, performed before induction of general anaesthesia, on analgesia postoperat…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New immune cells take aim at Virus-Linked lymphomas
Disease control Recruiting nowSubjects have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or T/NK-lymphoproliferative disease or severe chronic active Epstein Barr Virus (CAEBV) which has come back, is at risk of coming back, or has not gone away after treatment, including the best trea…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a chemo combo save lungs in scleroderma patients?
Disease control CompletedBy including in this study patients with significant worsening of their lung volumes and / or their DLCO (carbon monoxide diffusing capacity) in the previous year, on the basis of an open retrospective study we recently conducted, we hope to demonstrate that a strategy combining …
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
New balloon treatment may replace surgery for early esophageal cancer
Disease control CompletedFirst intent treatment for superficial circular esophageal neoplasm is surgical resection. Endoscopic mucosal resection is not recommended due to the high rate of subsequent esophageal stenosis (higher than 80%). Surgical limits are related to a high level of morbidity due, in p…
Phase 4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
When is the best time to exercise during breast cancer treatment?
Symptom relief OngoingThe purpose of this study is to compare the effects of aerobic exercise training during and after chemotherapy for women who have recently been diagnosed with early-stage breast cancer. The participant will be instructed to self-report the session information to ExOnc staff at o…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans
Knowledge-focused CompletedThis retrospective cohort study evaluated the performance of non-invasive risk scores for predicting de novo hepatocellular carcinoma in adults with hepatitis C virus-related compensated advanced chronic liver disease who achieved sustained virological response after sofosbuvir-b…
Sponsor: Siriraj Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could a Child's own cord blood stem cells restore hearing?
Disease control CompletedTo determine if autologous human umbilical cord blood infusion in children with acquired hearing loss is safe, feasible, improves inner ear function, audition and language development.
Phase 1 • Sponsor: James Baumgartner, MD • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for GVHD patients: nilotinib steps in when imatinib fails
Disease control CompletedOpen label non-randomized multicenter phase 2 trial with direct individual benefice
Phase 2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can early organ damage be spotted in new hypertension?
Knowledge-focused CompletedThe objective of this study is to know prevalence of clinical or subclinical target organ damages in Korea hypertensives by constructing nationwide hypertension registry. We will register 5000 consecutive patients with incident hypertension at 20 major university hospitals in Sou…
Sponsor: Dongtan Sacred Heart Hospital • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Balloon breakthrough: No-Stent fix for clogged heart arteries shows promise
Disease control CompletedThe CTO-DENOVO study is a multicenter registry of consecutive patients with de novo coronary chronic total occlusions (CTO) undergoing successful CTO recanalization with the use of drug-coated balloon (DCB)-only strategy. The primary endpoint is target lesion failure at 6 months.…
Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can freezing tumors control prostate cancer recurrence?
Disease control OngoingThe purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 26, 2026 13:59 UTC
-
Breast cancer study: does adding trastuzumab to Pre-Surgery chemo improve outcomes?
Disease control CompletedThis phase II trial studies the side effects and how well giving paclitaxel and cyclophosphamide with or without trastuzumab before surgery works in treating patients with previously untreated breast cancer. Drugs used in chemotherapy, such as paclitaxel and cyclophosphamide, wor…
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Experimental combo therapy for brain cancer shows promise in early trial
Disease control Stopped earlyTo determine the efficacy of Pulse Reduced Dose Rate (PRDR) radiation when given in 27 fraction over 5.5 weeks with concurrent bevacizumab followed by adjuvant bevacizumab until time of progression in patients with recurrent high grade gliomas (grade III and grade IV). Patients w…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation combo aims to shrink sarcomas before surgery
Disease control Recruiting nowThis research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention. Phase I studies also try to define the appropriate dose of the investigational therapy to use for further studies. "Investigational" means that the interve…
Phase 1/2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Stem cell transplant or drug combo: which works better for myeloma?
Disease control CompletedThe purpose of this study is to see whether pomalidomide (also known as Pomalyst) reduces the number of myeloma cells in the bones, and to see what is the best way to use pomalidomide in patients with myeloma. To do this, the investigators want to compare two types of treatment u…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 16:52 UTC